[Disseminated necrotizing leukoencephalopathy].
Araga
Shigeru
S
Department of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University.
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D001921:Brain / Q000473:pathology; D003704:Dementia / Q000209:etiology; D003937:Diagnosis, Differential; D006801:Humans; D007278:Injections, Spinal; D002955:Leucovorin / Q000627:therapeutic use; D004684:Leukoencephalitis, Acute Hemorrhagic / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D008775:Methylprednisolone / Q000008:administration & dosage; D011379:Prognosis; D020551:Pulse Therapy, Drug; D014057:Tomography, X-Ray Computed
D000964:Antimetabolites, Antineoplastic; D002955:Leucovorin; D008775:Methylprednisolone; D008727:Methotrexate